SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001108205-24-000054
Filing Date
2024-05-23
Accepted
2024-05-23 16:11:48
Documents
1
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716495080.html 4  
1 FORM 4 wk-form4_1716495080.xml 4 4871
  Complete submission text file 0001108205-24-000054.txt   6373
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Dentzer James E (Reporting) CIK: 0001400977 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 24978319